Back
ESC2025 Premium Access

Plasma levels measurement of the four direct oral anticoagulants in patients with atrial fibrillation at the time of acute thromboembolic and bleeding events

Session: Unmet needs in anticoagulant pharmacotherapy
Topic: Anticoagulants
Speaker: Doctor R. Mazza (Milan, IT)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Riccardo Mazza

IRCCS San Raffaele Scientific Institute, Milan (Italy)
0 follower

7 more presentations in this session

Clinical impact of kidney function in patients with atrial fibrillation receiving oral anticoagulants

Speaker: Doctor Y. Matsuoka (Osaka, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Navigating optimal antithrombotic therapy in atrial fibrillation patients with PCI: insights from the EPIC-CAD trial

Speaker: Doctor S. Wee (Seoul, KR)

Access
Abstract
Slides
Video
Like
Thumbnail

Efficacy and safety of direct oral anticoagulants for treatment of left ventricular thrombus

Speaker: Doctor K. Abraham (Stony Brook, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Direct oral anticoagulants versus warfarin for left ventricular thrombus

Speaker: Doctor J. Kassab (Dallas, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Pharmacokinetics and pharmacodynamics of SHR-2004, a novel humanized monoclonal antibody targeting factor XI, in patients with atrial fibrillation

Speaker: Professor J. Jiang (Hangzhou, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Unmet needs in anticoagulant pharmacotherapy

Speakers: Doctor R. Mazza, Doctor Y. Matsuoka, Doctor S. Wee, Doctor K. Abraham, Doctor J. Kassab...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources